Pulmonx (LUNG) Total Non-Current Liabilities (2019 - 2025)
Pulmonx's (LUNG) quarterly Total Non-Current Liabilities came in at $75.2 million in Q4 2025, up 94.15% quarter-over-quarter from $38.7 million in Q3 2022.
Powered by 
Analysis
Pulmonx (LUNG) Total Non-Current Liabilities (2019 - 2025) Analysis & Trends
Pulmonx (LUNG) has reported Total Non-Current Liabilities for 5 consecutive years, with $75.2 million the latest figure, recorded in Q4 2025.
- On a quarterly basis, Total Non-Current Liabilities changed N/A year-over-year to $75.2 million in Q4 2025; TTM through Dec 2025 was $75.2 million, a N/A change from a year earlier, with the FY2025 full-year figure at $75.2 million, changed N/A from the prior year.
- Total Non-Current Liabilities was $75.2 million for Q4 2025 at Pulmonx, up from $38.7 million in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $75.2 million in Q4 2025 and troughed at $38.7 million in Q3 2022.
- A 3-year average of $47.3 million and a median of $40.5 million in 2022 frame the typical range for Total Non-Current Liabilities.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 40.46 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 21.28 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 17.56 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 2.57 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 6.34 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 3.68 Bn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Pulmonx | 75.94 Mn | 6.19 Mn | - | 75.18 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 75.18 Mn |
| Sep 30, 2022 | 38.72 Mn |
| Jun 30, 2022 | 40.37 Mn |
| Mar 31, 2022 | 40.53 Mn |
| Dec 31, 2021 | 41.76 Mn |
| Sep 30, 2020 | 68.63 Mn |
| Dec 31, 2019 | 34.37 Mn |